menu
    • menu

    Company profile for MyoKardia

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MyoKardia’s scientists have discovered a portfolio of small molecule therapeutics aimed at the muscle proteins of the heart and intended to correct the excessive contraction, impaired relaxation or insufficient contraction underlying diseases of systolic and diastolic dysfunction. We are applying a precision medicine approach to develop our therapeutic candidates for patient populations with shared characteristics, such as c...
    MyoKardia’s scientists have discovered a portfolio of small molecule therapeutics aimed at the muscle proteins of the heart and intended to correct the excessive contraction, impaired relaxation or insufficient contraction underlying diseases of systolic and diastolic dysfunction. We are applying a precision medicine approach to develop our therapeutic candidates for patient populations with shared characteristics, such as causal genetic mutations or disease subtypes. Our clinical-stage pipeline includes: mavacamten (formerly 461) in Phase 3 and Phase 2 clinical trials for hypertrophic cardiomyopathies (HCM).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MyoKardiaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1000 Sierra Point Parkway Brisbane, CA 94005
    Telephone
    Telephone
    (650) 741-0900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://myokardia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/myokardia/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MyoKardia

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kardigan launches with cozy $300M, late-stage portfolio
    Kardigan launches with cozy $300M, late-stage portfolio

    11 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/kardigan-launches-cozy-300-million-series-and-collection-late-stage-cardiovascular-assets

    FIERCE BIOTECH
    11 Jan 2025
    Share Share
    BMS wins FDA approval of $13B cardio drug mavacamten
    BMS wins FDA approval of $13B cardio drug mavacamten

    29 Apr 2022

    // J. Gardner BIOPHARMADIVE

    https://www.biopharmadive.com/news/bristol-myers-fda-approval-heart-drug-camzyos-myokardia/622732/

    J. Gardner BIOPHARMADIVE
    29 Apr 2022
    Share Share
    Evelo Biosciences names former Alnylam, MyoKardia CEOs as strategic advisors
    Evelo Biosciences names former Alnylam, MyoKardia CEOs as strategic advisors

    21 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/21/2426196/0/en/Evelo-Biosciences-Appoints-John-Maraganore-Ph-D-and-Tassos-Gianakakos-as-Strategic-Advisors.html#:~:text=(Nasdaq%3AEVLO)%2C%20a,joined%20Evelo%20as%20strategic%20advisors.

    GLOBENEWSWIRE
    21 Apr 2022
    Share Share
    Bristol Myers uncorks more winning data for blockbuster-potential heart drug
    Bristol Myers uncorks more winning data for blockbuster-potential heart drug

    16 Feb 2022

    // Kyle Blankenship ENDPTS

    https://endpts.com/with-delayed-review-date-looming-bristol-myers-uncorks-more-winning-data-for-blockbuster-potential-heart-drug/

    Kyle Blankenship ENDPTS
    16 Feb 2022
    Share Share
    FDA delays its decision on Bristol Myers' $13B heart drug another three months
    FDA delays its decision on Bristol Myers' $13B heart drug another three months

    20 Nov 2021

    // N. DeFeudis ENDPTS

    https://endpts.com/fda-delays-its-decision-on-bristol-myers-13b-heart-drug-another-three-months/

    N. DeFeudis ENDPTS
    20 Nov 2021
    Share Share
    A couple months ahead of PDUFA data, BMS rolls out long-term data for mavacamten
    A couple months ahead of PDUFA data, BMS rolls out long-term data for mavacamten

    13 Nov 2021

    // N. DeFeudis ENDPTS

    https://endpts.com/a-couple-months-ahead-of-its-pdufa-data-bristol-myers-rolls-out-long-term-data-for-mavacamten/

    N. DeFeudis ENDPTS
    13 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search